News

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...
Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...
The FDA approved Yeztugo (lenacapavir), a twice-yearly injection that prevents HIV with up to 99.9% effectiveness, showing ...